Education
About Us
Working with TipRanks
Follow Us
Active Biotech AB (SE:ACTI)
:ACTI
ACTI Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.06 - kr0.52
Previous CloseN/A
Volume903.68K
Average Volume (3M)6.99M
Market Cap
€107.02M
Enterprise Valuekr40.68M
Total Cash (Recent Filing)kr27.40M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-0.45
Next Earnings
May 08, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding1,230,164,700
10 Day Avg. Volume9,837,066
30 Day Avg. Volume6,989,289
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
ACTI FAQ
What was Active Biotech AB’s price range in the past 12 months?
Active Biotech AB lowest stock price was kr0.06 and its highest was kr0.52 in the past 12 months.
What is Active Biotech AB’s market cap?
Active Biotech AB’s market cap is €107.02M.
When is Active Biotech AB’s upcoming earnings report date?
Active Biotech AB’s upcoming earnings report date is May 08, 2025 which is in 11 days.
How were Active Biotech AB’s earnings last quarter?
Active Biotech AB released its earnings results on Feb 13, 2025. The company reported -kr0.017 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.017.
Is Active Biotech AB overvalued?
According to Wall Street analysts Active Biotech AB’s price is currently Overvalued.
Does Active Biotech AB pay dividends?
Active Biotech AB does not currently pay dividends.
What is Active Biotech AB’s EPS estimate?
Active Biotech AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Active Biotech AB have?
Active Biotech AB has 1,230,164,700 shares outstanding.
What happened to Active Biotech AB’s price movement after its last earnings report?
Active Biotech AB reported an EPS of -kr0.017 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.709%.
Which hedge fund is a major shareholder of Active Biotech AB?
Currently, no hedge funds are holding shares in SE:ACTI
---
Company Description
Active Biotech AB
Active Biotech AB (ACTI) is a Swedish biotechnology company specializing in the development of pharmaceuticals for the treatment of autoimmune and inflammatory diseases, as well as cancer. The company focuses on research and development to create innovative therapies that address unmet medical needs. Active Biotech's core products include drug candidates in various stages of clinical trials, targeting conditions such as multiple sclerosis, cancer, and inflammatory diseases.
---
Technical Analysis
Alligator Bioscience AB
―
Biosergen AB
―
Biovica International AB Class B
―
Nanologica AB
―
---